Canalevia™-CA1 (crofelemer) Delayed-Release Tablets

125 mg, 60/Bottle

VEDCO INC

Manufacturer Item #:JAH 111-060

Patterson Item #:07-894-7034

Package Quantity:

60/Bottle

Active Ingredient:

Crofelemer

Presentation:

Tablet

See My Price

MSDS / SDS

Overview

Product Specifications

Canalevia™-CA1 (crofelemer) Delayed-Release Tablets conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs.

Normalizes water flow to reinstate normal function in the GI tract and is an antidiarrheal, enteric-coated tablet for oral administration
Acts locally and it is not absorbed into the blood stream, providing a well tolerated and nontoxic drug product
Only FDA conditionally approved product for chemotherapy-induced diarrhea (CID) in dogs
Modulates the hypersecretion of CI in CID and normalizes water influx into the intestinal lumen
Non-opioid
Reduces the instances of watery stools
Reduces costly accidents around the home, and improves the quality of life for dogs undergoing chemotherapy and their owners

NDC Number:

86149-0111-60

Active Ingredient:

Crofelemer

Color Of Medicine:

White

Package Quantity:

60/Bottle

Strength:

125 mg

Presentation:

Tablet

Delivery Type:

Oral

Reconstitution Required:

Container Capacity:

Bottle